Veradigm | MDRX - Capital Ordinário

Preço das Ações
4.21
Mudança Diária
-0.10 -2.32%
Mensal
-9.46%
Anual
-0.94%
Q2 Previsão
4.12




Capital Ordinário Alterar Data
Alcidion AUD 1.34B 0 2025-12
Ambu A/S DKK 266.56M 0 2025-12
Amplifon EUR 219.94M 2.92M 2025-09
Cardinal Health USD 238M 1000K 2025-09
Centene USD 491.76M 343K 2025-12
Charles River Laboratories USD 49.22M 2K 2025-12
Cigna USD 263.46M 3.14M 2025-12
Coloplast 225.37M 0 2025-12
Computer Programs Systems USD 14.99M 14.97M 2025-12
Convatec Group USD 251.5M 0 2024-12
CVS Health USD 1.27B 1000K 2025-12
Elevance Health USD 222.24M 2.94M 2025-12
General Electric Aerospace USD 1.05B 6.05M 2025-12
Gulf Medical Proj AED 698.92M 0 2025-12
Humana USD 120.59M 318K 2025-12
IQVIA Holdings USD 169.6M 700K 2025-12
Laboratory Of America USD 82.2M 700K 2025-12
Maximus USD 616.31M 13.06M 2025-03
McKesson USD 280M 156M 2025-12
Med Life RON 530.82M 0 2025-12
Molina Healthcare USD 51M 0 2025-12
Omnicell USD 44.88M 1.06M 2025-12
Oriola-kd EUR 185.24M 0 2025-12
Owens Minor USD 76.39M 911K 2025-12
Quest Diagnostics USD 110M 1000K 2025-12
Rede D'or Sao Luiz BRL 2.21B 333.38K 2025-12
Siemens Healthineers EUR 1.12B 0 2025-09
Sonova Holding CHF 59.61M 10.56K 2025-06
Supermax Corporation Bhd MYR 3.06B 0 2025-12
UnitedHealth USD 905.84M 161K 2025-12
Veeva Systems USD 164.38M 39K 2025-12
Veradigm USD 106.07M 103.28M 2022-12
Xerox USD 126M 2M 2025-03